Literature DB >> 16413892

Comparison of remifentanil with fentanyl for deep sedation in oral surgery.

Gabriel F Lacombe1, James L Leake, Cameron M L Clokie, Daniel A Haas.   

Abstract

PURPOSE: The aim of this study was to compare recovery for oral surgery patients given a deep sedation regimen of midazolam, propofol, and remifentanil with a standard control of fentanyl in place of remifentanil.
MATERIALS AND METHODS: This investigation was designed as a randomized, prospective, single-blinded controlled study. Group 1, the control, received midazolam 0.03 mg/kg, fentanyl 1 microg/kg, and propofol initially at 140 microg/kg/min. Group 2 received midazolam 0.03 mg/kg, remifentanil: propofol (1:500) given at an initial propofol infusion rate of 40 microg/kg/min. Outcome measures included time to response to verbal command, Aldrete score = 9, Postanesthesia Discharge Scoring System = 7, and assessment by the Digit Symbol Substitution Test.
RESULTS: Forty-seven subjects were entered in the study. Baseline findings were homogenous between the 2 groups. Subjects in group 2 recovered earlier (P < .005) and required less propofol for both the induction (0.8 +/- 0.4 versus 1.2 +/- 0.6 mg/kg; mean +/- SD, P < .01) and maintenance of deep sedation (46 +/- 9 versus 131 +/- 17 microg/kg/min; P < .005). There were minor differences in vital signs.
CONCLUSIONS: This study demonstrated that this remifentanil regimen provided significantly more rapid recovery and used significantly less propofol compared with the fentanyl regimen.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16413892     DOI: 10.1016/j.joms.2005.10.026

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  7 in total

1.  Recovery of psychomotor function after total intravenous anesthesia with remifentanil-propofol or fentanyl-propofol.

Authors:  Aki Takayama; Shigeki Yamaguchi; Kazuyoshi Ishikawa; Mio Shinozaki; Yoshiyuki Kimura; Masaru Nagao; Toshimitsu Kitajima
Journal:  J Anesth       Date:  2011-11-03       Impact factor: 2.078

2.  Usefulness of Continuous Low-Dose Fentanyl in Combination with Dexmedetomidine and Midazolam for Intravenous Sedation: A Randomised Controlled Trial.

Authors:  Yoko Okumura; Aiji Sato Boku; Naoko Tachi; Mayuko Kanazawa; Miko Kawabata; Masahiro Okuda
Journal:  Biomed Res Int       Date:  2022-05-16       Impact factor: 3.246

3.  A Comparison between Sedative Effect of Propofol-Fentanyl and Propofol-Midazolam Combinations in Microlaryngeal Surgeries.

Authors:  Masih Ebrahimi Dehkordi; Seyyed Sajjad Razavi; Sirous Momenzadeh
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

4.  Sedation in oral and maxillofacial day care surgery: A comparative study between intravenous dexmedetomidine and midazolam.

Authors:  Niranjan Mishra; Krishna Gopal Birmiwal; Nibedita Pani; Subhrajit Raut; Gaurav Sharma; Krushna Chandra Rath
Journal:  Natl J Maxillofac Surg       Date:  2016 Jul-Dec

Review 5.  Remifentanil-induced postoperative hyperalgesia: current perspectives on mechanisms and therapeutic strategies.

Authors:  Cristina Santonocito; Alberto Noto; Claudia Crimi; Filippo Sanfilippo
Journal:  Local Reg Anesth       Date:  2018-04-09

6.  Comparison of the effects of target-controlled infusion-remifentanil/midazolam and manual fentanyl/midazolam administration on patient parameters in dental procedures.

Authors:  Doug Lobb; Nazila Ameli; Silvia Ortiz; Hollis Lai
Journal:  J Dent Anesth Pain Med       Date:  2022-03-25

7.  Remifentanil versus Fentanyl for Assisted Reproductive Technologies: Effect on Hemodynamic Recovery from Anesthesia and Outcome of ART Cycles.

Authors:  Mohammad Hossein Jarahzadeh; Robab Davar; Mohammad Reza Hajiesmaeili; Ahmad Entezari; Fatemeh Musavi
Journal:  Int J Fertil Steril       Date:  2011-09-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.